Volume 24, Issue 4 pp. 553-559
Original Article

Evaluation of sleep disorders in cancer patients based on Pittsburgh Sleep Quality Index

Tulay Akman MD

Corresponding Author

Tulay Akman MD

Medical oncology specialist

Tepecik Education and Research Hospital, Division of Medical Oncology, Izmir, Turkey

Correspondence address: Tulay Akman, MD, PhD student, Tepecik Education and Research Hospital, Department of Medical Oncology, Gaziler Caddesi, No: 468, Yenisehir, Izmir, Turkey (e-mail: [email protected])Search for more papers by this author
Tugba Yavuzsen MD

Tugba Yavuzsen MD

Associated Professor of Medical oncology

Dokuz Eylul University Medical School, Division of Medical Oncology, Izmir, Turkey

Search for more papers by this author
Zeynep Sevgen MD

Zeynep Sevgen MD

Internal Medicine Specialist

Dokuz Eylul University Medical School, Department of Internal Medicine, Izmir, Turkey

Search for more papers by this author
Hulya Ellidokuz MD

Hulya Ellidokuz MD

Professor of Public Health

Dokuz Eylul University Medical School, Department of Preventive Oncology, Izmir, Turkey

Search for more papers by this author
Ahmet Ugur Yilmaz MD

Ahmet Ugur Yilmaz MD

Professor of Medical oncology

Medical Park, Izmir University, Division of Medical Oncology, Izmir, Turkey

Search for more papers by this author
First published: 01 March 2015
Citations: 82
Commercial or financial support: Authors have no conflict of interest (financial or otherwise). No commercial support was obtained for this study.

Abstract

Insomnia, poor sleep quality and short sleep durations are the most common problems seen in cancer patients. More studies are needed about sleep disorders in cancer patients. In our study, we aimed to investigate the prevalence of sleep disorders and the impact of these problems on the quality of life in cancer patients. Pittsburgh Sleep Quality Index (PSQI) was given to a total of 314 patients. The psychometric evaluation of the Turkish version of PSQI in cancer patients revealed that 127 (40.4%) patients had global PSQI scores >5, indicating poor sleep quality. There was no statistically significant relationship between PSQI scores and sexuality, marital status, cancer stage and chemotherapy type (P > 0.05); while the patients with bone and visceral metastasis had much lower PSQI scores (P = 0.006). Patients with Eastern Cooperative Oncology Group performance scores of 3 or more had also significantly lower PSQI scores (P = 0.02). In conclusion, PSQI questionnaire may be used to evaluate the sleep disorders in cancer patients. Consistent use of multi-item measures such as PSQI with established reliability and validity would improve our understanding of difficulties experienced by cancer patients with chronic insomnia.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.